Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J

Group Details the Case for Urgent Change at Cano Following an Extended Period of Underperformance, Failed Capital Allocation, and Extremely Poor Governance and Strategic Execution Urges Stockholders to WITHHOLD Support for Incumbent Directors as Parties Await a Resolution of Litigation to Compel Company to Reopen Window for Nominating Director Candidates and Making Proposals Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE:CANO), today announced that they have submitted a notice to the

Consultation and resources available at no cost to local community Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the aftermath of Hurricane Ian. The toll-free number to access free, confidential consultation services is 1-800-327-7451. Magellan confidential consultation services are offered at no charge to the community to assist individuals as they work to cope with the feelings of fear, sadness, anger, or hopelessness related to these kinds of natural disasters. Crisis line callers may also seek information and guidance to other available resources, such as community-based support. Tip sheets with resources spe

4 - MAGELLAN HEALTH INC (0000019411) (Issuer)

4 - MAGELLAN HEALTH INC (0000019411) (Issuer)

4 - MAGELLAN HEALTH INC (0000019411) (Issuer)

15-12B - MAGELLAN HEALTH INC (0000019411) (Filer)

S-8 POS - MAGELLAN HEALTH INC (0000019411) (Filer)

S-8 POS - MAGELLAN HEALTH INC (0000019411) (Filer)

Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J

Magellan Health, Inc. today announced it has appointed Tom Britt as chief information officer for Magellan Health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220808005111/en/Tom Britt (Photo: Business Wire) Britt will work closely with Magellan's executive leadership to create, develop and implement information technology strategy and digital solutions while leveraging best practices and delivering data-enhanced products and services through innovative technology platforms. "Tom is a strong leader with over 25 years of significant leadership experience in building innovative digital products and solutions while leading high

  Magellan Health, Inc., one of the nation's leaders in behavioral health, today announced it has appointed Caroline Carney, MD, MSc, FAPM, CPHQ, as president of behavioral health for its subsidiary, Magellan Healthcare. In this key leadership role, Dr. Carney will advance Magellan Health's clinical mission and further position the company's significant leadership capabilities in behavioral health, including collaborative and integrated approaches that enhance member experience across the continuum of care. Dr. Carney will also continue in her role as chief medical officer of Magellan Health, leading the development and implementation of innovative, integrated clinical programs for custo

Magellan Health, Inc. (NASDAQ:MGLN) today announced financial results for the third quarter ended September 30, 2021, as summarized below:             Three Months Ended   Nine Months Ended Sept 30   Sept 30 (In millions, except per share amounts)           Continuing Operations     2021         2020     Chg     2021     2020   Chg Net revenue $   1,254.1     $   1,170.1     7.2 %   $ 3,636.5   $ 3,392.6   7.2 % Net (loss) income $   (0.1 )   $   (17.3 )   NM     $ 21.9   $ 28.7   -23.7 % Segment profit [1] $   38.

Magellan Health, Inc. (NASDAQ:MGLN) today announced financial results for the second quarter ended June 30, 2021, as summarized below: Three Months Ended     Six Months Ended June 30     June 30 (In millions, except per share amounts)                         Continuing Operations     2021         2020   Chg         2021       2020   Chg Net revenue $   1,220.8     $   1,100.1   11.0 %   $   2,382.4   $   2,222.5   7.2 % Net income (loss) $   (6.5 )   $   47.1   -113.7 %   $   22.0   $   46.0   -52.1 % Segment profit [1]

PHOENIX--(BUSINESS WIRE)--Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and the year ended December 31, 2020, as summarized below:   Three Months Ended Twelve Months Ended December 31 December 31 (In millions, except per share amounts) Continuing Operations 2020 2019 Chg 2020 2019 Chg Net revenue $ 1,185.0   $ 1,133.8 4.5 % $ 4,577.5 $ 4,565.6 0.3 % Net (loss) income $ (24.7 ) $ 9.5 NM   $ 4.0 $ 12.6 -67.9 % Segment profit [1] $ 11.3   $ 55.9 -79.8 % $ 14

SC 13D/A - MAGELLAN HEALTH INC (0000019411) (Subject)

SC 13G - MAGELLAN HEALTH INC (0000019411) (Subject)

SC 13D/A - MAGELLAN HEALTH INC (0000019411) (Subject)